These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 10629764)

  • 1. Nicotine abstinence in the mouse.
    Isola R; Vogelsberg V; Wemlinger TA; Neff NH; Hadjiconstantinou M
    Brain Res; 1999 Dec; 850(1-2):189-96. PubMed ID: 10629764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The nicotinic antagonist mecamylamine precipitates nicotine abstinence syndrome in the rat.
    Malin DH; Lake JR; Carter VA; Cunningham JS; Hebert KM; Conrad DL; Wilson OB
    Psychopharmacology (Berl); 1994 Jun; 115(1-2):180-4. PubMed ID: 7862893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ability of baclofen to prevent somatic manifestations and neurochemical changes during nicotine withdrawal.
    Varani AP; Moutinho LM; Calvo M; Balerio GN
    Drug Alcohol Depend; 2011 Dec; 119(1-2):e5-12. PubMed ID: 21733642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The nitric oxide synthesis inhibitor nitro-L-arginine (L-NNA) attenuates nicotine abstinence syndrome in the rat.
    Malin DH; Lake JR; Shenoi M; Upchurch TP; Johnson SC; Schweinle WE; Cadle CD
    Psychopharmacology (Berl); 1998 Dec; 140(3):371-7. PubMed ID: 9877017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of CB1 cannabinoid receptors modifies nicotine behavioural responses, but not nicotine abstinence.
    Castañé A; Valjent E; Ledent C; Parmentier M; Maldonado R; Valverde O
    Neuropharmacology; 2002 Oct; 43(5):857-67. PubMed ID: 12384171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Removal of continuous nicotine infusion produces somatic but not behavioral signs of withdrawal in mice.
    Kwilasz AJ; Harris LS; Vann RE
    Pharmacol Biochem Behav; 2009 Nov; 94(1):114-8. PubMed ID: 19660491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoamine oxidase inhibition dramatically prolongs the duration of nicotine withdrawal-induced place aversion.
    Guillem K; Vouillac C; Koob GF; Cador M; Stinus L
    Biol Psychiatry; 2008 Jan; 63(2):158-63. PubMed ID: 17643399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mecamylamine-precipitated nicotine-withdrawal aversion in rats.
    Suzuki T; Ise Y; Tsuda M; Maeda J; Misawa M
    Eur J Pharmacol; 1996 Oct; 314(3):281-4. PubMed ID: 8957247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central histaminergic transmission modulates the expression of chronic nicotine withdrawal induced anxiety-like and somatic behavior in mice.
    Patel D; Vishwakarma PK; Patel R; Jain NS
    Behav Brain Res; 2021 Feb; 399():112997. PubMed ID: 33166570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'Nicotine deprivation effect' in rats with intermittent 23-hour access to intravenous nicotine self-administration.
    O'Dell LE; Koob GF
    Pharmacol Biochem Behav; 2007 Feb; 86(2):346-53. PubMed ID: 17292952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of the expression of mecamylamine-precipitated nicotine withdrawal by calcium channel antagonists.
    Biala G; Weglinska B
    Pharmacol Res; 2005 May; 51(5):483-8. PubMed ID: 15749464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged nicotine dependence associated with extended access to nicotine self-administration in rats.
    Paterson NE; Markou A
    Psychopharmacology (Berl); 2004 Apr; 173(1-2):64-72. PubMed ID: 14712336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mecamylamine elicits withdrawal-like signs in rats following a single dose of nicotine.
    Harris AC; Manbeck KE; Schmidt CE; Shelley D
    Psychopharmacology (Berl); 2013 Jan; 225(2):291-302. PubMed ID: 22868410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotine withdrawal in adolescent and adult rats.
    O'Dell LE; Bruijnzeel AW; Ghozland S; Markou A; Koob GF
    Ann N Y Acad Sci; 2004 Jun; 1021():167-74. PubMed ID: 15251887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bupropion attenuates nicotine abstinence syndrome in the rat.
    Malin DH; Lake JR; Smith TD; Khambati HN; Meyers-Paal RL; Montellano AL; Jennings RE; Erwin DS; Presley SE; Perales BA
    Psychopharmacology (Berl); 2006 Mar; 184(3-4):494-503. PubMed ID: 16163521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions between age and the aversive effects of nicotine withdrawal under mecamylamine-precipitated and spontaneous conditions in male Wistar rats.
    Shram MJ; Siu EC; Li Z; Tyndale RF; Lê AD
    Psychopharmacology (Berl); 2008 Jun; 198(2):181-90. PubMed ID: 18385986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral manifestations of the nicotine abstinence syndrome in the rat: peripheral versus central mechanisms.
    Hildebrand BE; Nomikos GG; Bondjers C; Nisell M; Svensson TH
    Psychopharmacology (Berl); 1997 Feb; 129(4):348-56. PubMed ID: 9085404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Rhodiola rosea L. extract on affective and physical signs of nicotine withdrawal in mice.
    Mattioli L; Perfumi M
    J Psychopharmacol; 2011 Mar; 25(3):402-10. PubMed ID: 19939867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological modulation of farnesyltransferase subtype I attenuates mecamylamine-precipitated nicotine withdrawal syndrome in mice.
    Singh TG; Rehni AK; Arora SK
    Behav Pharmacol; 2013 Dec; 24(8):668-77. PubMed ID: 24196026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of nitric oxide synthase inhibitors in attenuating nicotine withdrawal in rats.
    Jain R; Mukherjee K; Mohan D
    Pharmacol Biochem Behav; 2008 Feb; 88(4):473-80. PubMed ID: 18031800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.